Cafepharma Today

October 24 2024 - Weight-loss drugs didn't curb health costs within two years
Weight-loss drugs didn't curb health costs within two years
GSK answers Pfizer's RSV approval with data targeting matching nod in younger adults
Why pharma megamergers may become a relic of the past
Lundbeck planning for four novel drugs in phase 3 in 2026
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Pfizer declares regular dividend of 32 cents
Yahoo/AP
Saturday, October 25, 2008 - 12:47pm
tags:
Acusphere Announces Signing of a Definitive Agreement with Cephalon
International Business Times
Saturday, October 25, 2008 - 12:42pm
tags:
Calando Pharmaceuticals completes Phase I cancer trial
Pharmaceutical Business Review
Saturday, October 25, 2008 - 12:41pm
tags:
GSK Pays Affiris $28M Up Front in Alzheimer's Vaccine Deal
Bioworld
Saturday, October 25, 2008 - 12:23pm
tags:
Tempo Pharmacueticals changes its name
San Antonio Business Journal, TX
Saturday, October 25, 2008 - 12:21pm
tags:
Astellas Pharma Withdraws Europe Application For Antibiotic
Alibaba News Channel
Saturday, October 25, 2008 - 12:20pm
tags:
Pfizer to Pay $60 Million to Settle With States Over Promotion of Painkiller
New York Times
Saturday, October 25, 2008 - 12:19pm
tags:
Affymetrix Has Trouble Turning Around
Motley Fool
Saturday, October 25, 2008 - 12:16pm
tags:
Lilly's Results Run the Gamut
Motley Fool
Saturday, October 25, 2008 - 12:16pm
tags:
Heska Announces Receipt of Letter from Nasdaq
Yahoo
Saturday, October 25, 2008 - 12:15pm
tags:
VioQuest Pharmaceuticals Provides Strategic Alternatives Review and Operations Update
Yahoo
Saturday, October 25, 2008 - 12:14pm
tags:
AEterna Zentaris Receives Notification from Nasdaq Relating to Minimum Bid Price
Yahoo
Saturday, October 25, 2008 - 12:13pm
tags:
Opexa upbeat on MS drug study
Bizjournals.com
Friday, October 24, 2008 - 10:40am
tags:
Health Winners & Losers: Amgen
The Street.com
Friday, October 24, 2008 - 10:39am
tags:
Improving the Use of Drugs Through Genes
Yahoo/Businessweek
Friday, October 24, 2008 - 10:37am
tags:
[video] They Just Don't Get Lilly!
The Street.com
Friday, October 24, 2008 - 10:36am
tags:
Eli Lilly says European panel takes negative view of Cymbalta to treat fibromyalgia
Yahoo/AP
Friday, October 24, 2008 - 10:33am
tags:
Are Pfizer and Lilly's ED Drugs Suffering from the Economic Slowdown?
Seeking Alpha
Friday, October 24, 2008 - 10:32am
tags:
U.S. Doctors Prescribe Drugs for Placebo Effect, Survey Shows
Bloomberg
Friday, October 24, 2008 - 10:31am
tags:
Bristol-Myers Chief Has `Long List' of Deal Targets
Bloomberg
Friday, October 24, 2008 - 10:30am
tags:

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

A Pfight at Pfizer
In the Pipeline
Clinical Trial Volunteers, And Others
In the Pipeline
The 340B Program Reached $66 Billion in 2023—Up 23% vs. 2022: Analyzing the Numbers and HRSA’s Curious Actions
Drug Channels
HCN in Acetonitrile, You Say?
In the Pipeline
Informa Connect’s Trade and Channel Strategies
Drug Channels
AI Does Not Make It Easy
In the Pipeline
The Promise of a Direct-to-Patient Model—Breaking Down What’s Really Needed for Better Patient Access
Drug Channels
Accelerated Approval: What Is It Accomplishing?
In the Pipeline
Cleaning up "Scientific Reports": Can It Be Done?
In the Pipeline

Latest Jobs

Account Manager-Orlando, FL-Ophthalmics
Maitland, Florida, 32794
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Alafaya, Florida
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Union Park, Florida
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Bunker Hill Village, Texas
Sun Pharmaceutical Industries, Inc.
Account Manager-Phoenix, AZ-Oncology
Paradise Valley, Arizona, 85253
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Pasadena, Texas, 77505
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Cloverleaf, Texas
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Gotha, Florida, 34734
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Longwood, Florida, 32791
Sun Pharmaceutical Industries, Inc.
Territory Manager - Medical Dermatology, Richmond VA
Richmond
Sun Pharmaceutical Industries, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information